{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT00411723: Phase 1 Interventional Unknown status Multiple Sclerosis, Chronic Progressive
(2006)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03014076: Phase 1 Interventional Completed Breastcancer
(2008)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00019682: Phase 3 Interventional Completed Recurrent Melanoma
(1999)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04432337: Not Applicable Interventional Withdrawn Inflammatory Response
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01283373: Phase 1 Interventional Completed Prostate Cancer
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02598648: Not Applicable Interventional Unknown status Acute Respiratory Distress Syndrome
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03663088: Not Applicable Interventional Terminated Idiopathic Scoliosis
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03390296: Phase 1/Phase 2 Interventional Completed Recurrent Acute Myeloid Leukemia
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:sacituzumab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02384538: Phase 2 Interventional Completed Erosive Hand Osteoarthritis
(2015)
Source URL:
Class:
PROTEIN
